Koch Industries’s Amedisys AMED Stock Holding History

Koch Industries’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,238	Closed	-$316K	–	38
2018 Q1	$316K	Sell	5,238 -7,123	-58%	-$406K	0.03%	616
2017 Q4	$652K	Buy	+12,361	New	+$651K	0.1%	154

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Koch Industries's AMED Position: Q2 2018 in Review

Koch Industries sold out of Amedisys (AMED) in Q2 2018, closing a stake of 5,238 shares — an estimated $316K sold.

Koch Industries first reported a position in AMED in Q4 2017 and held it in 2 quarters. The position peaked at $652K in Q4 2017. 216 funds tracked by Wall St. Rank hold AMED as of Q2 2018.

Koch Industries reported no remaining Amedisys position as of Q2 2018 after selling out during the quarter.
Koch Industries sold 5,238 Amedisys shares in Q2 2018, an estimated $316K.
Koch Industries first reported a position in Amedisys in Q4 2017 and held it in 2 quarters.
Koch Industries's Amedisys position peaked at $652K in Q4 2017.
216 funds tracked by Wall St. Rank held Amedisys as of Q2 2018.

Based on Koch Industries's 13F filing for Q2 2018, filed 13 Aug 2018.